Description
Flupirtine maleate is an agonist at voltage-gated KCNQ/Kv7 K+ channels; opening of these channels on neurons facilitates M-current generation and decreases axonal excitability. In addition to its modulation of K+ channels, flupirtine maleate also inhibits NMDA receptors and shifts gating of GABA-A receptors to decrease circulating GABA concentrations. Flupirtine maleate is an effective non-sedative analgesic, showing benefit in clinical trials of neurosurgical patients. In animal models, this compound also attenuates development of and reverses established pulmonary arterial hypertension, suggesting antihypertensive activity.